F. Edmondson
Consigliere Generale presso ZAI LAB LIMITED
Patrimonio netto: 488 605 $ in data 31/05/2024
Posizioni attive di F. Edmondson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ZAI LAB LIMITED | Consigliere Generale | 07/08/2020 | - |
| Segretario Aziendale | 27/06/2022 | - |
Storia della carriera di F. Edmondson
Precedenti posizioni note di F. Edmondson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/06/2014 | 01/08/2020 |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Segretario Aziendale | - | - |
Formazione di F. Edmondson
| Washington & Lee University | Undergraduate Degree |
| Widener University School of Law | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Isole Cayman | 2 |
Posizioni
| Corporate Secretary | 2 |
| General Counsel | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ZAI LAB LIMITED | Health Technology |
| BIOGEN INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
- Borsa valori
- Insiders
- F. Edmondson
- Esperienza
